Poster Abstract Session:
150. Urinary Tract Infection
Friday, October 5, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID

Comparative Effectiveness of Antibiotic Therapy for the Outpatient Treatment of Urinary Tract Infections Among Otherwise Healthy, Premenopausal Women
Anne M. Butler, PhD, MS; Matthew R. Keller, MA; Michael J. Durkin, MD MPH; Vikas R. Dharnidharka, MD, MPH; Margaret A. Olsen, PhD, MPH
Identifying Risk Factors for Recurrent Urinary Tract Infections among Female Outpatients
Brittany Morgan, MPH Candidate; Gregory B. Tallman, PharmD, MS; Miriam R. Elman, MPH, MS; David T. Bearden, PharmD; Jessina C. McGregor, PhD
No Benefit to Treating Male UTI for Longer than 7 Days: An Outpatient Database Study
George Germanos, MD; Barbara W. Trautner, MD, PhD, FIDSA; Roger Zoorob, MD, MPH; Dimitri M. Drekonja, MD, MS, FIDSA; Jason Salemi, PhD, MPH; Kalpana Gupta, MD, MPH; Larissa Grigoryan, MD PhD
Patient demographics and comorbidity profiles associated with hospitalized patients admitted with resistant vs. susceptible urinary tract infections (UTI): A multicenter analysis
Jon Bruss, MD, MSPH, MBA; David Melnick, MD; Akash Jain, PhD; John Murray, MPH; Ian Critchley, PhD; Stephen Kurtz, MS; Vikas Gupta, PharmD, BCPS
Association of Antibiotic Treatment Duration with First Recurrence of Uncomplicated Urinary Tract Infection in Pediatric Patients
Titilola M. Afolabi, PharmD, BCPS, BCPPS; Kellie J. Goodlet, PharmD, BCPS; Kathleen A. Fairman, MA
  • IDWeek poster 7-23-18.pdf (252.0 kB)
  • Urinary Tract Infections (UTIs) in the First Year Post-Renal Transplant: Risks and Opportunities
    Brian Bohn, PharmD; Vasilios Athans, PharmD, BCPS; Christopher Kovacs, MD; Brian Stephany, MD; Michael Spinner, PharmD
  • ID week 2018 Bohn 1508.pdf (313.6 kB)
  • Clinical Significance of Staphylococcus aureus Bacteriuria
    Jennifer Masel, MD; Edwin Kamau, PhD; Dan Brooks, PhD; Todd Gleeson, MD
    Treatment of Asymptomatic Bacteriuria prior to Transcatheter Aortic Valve Replacement
    Alexandra Clay, BA; Kirthana R. Beaulac, PharmD; Gabriela M Andujar Vazquez, MD; Shira Doron, MD, MS, FIDSA; David Snydman, MD, FIDSA
  • 1510_IDWPOSTER.pdf (313.5 kB)
  • Variation in Outpatient Urine Testing Practices for Uncomplicated Urinary Tract Infections
    Sonya Liu, BA; Jahnavi Bongu, MPH; Matthew Keller, MA; Anne M. Butler, PhD, MS; Margaret A. Olsen, PhD, MPH; Michael J Durkin, MD MPH
    Patient-based stratification of weighted-incidence syndromic antibiogram (WISCA) for empiric antibiotic prescribing
    Courtney Hebert, MD, MS; Erinn Hade, PhD; Protiva Rahman, BS; Mark Lustberg, MD, PhD; Courtney Dewart, RN, MPH; Preeti Pancholi, PhD; Kurt Stevenson, MD, MPH, FSHEA
    Evaluation of Antibiotic Prescribing Practices for Lower Urinary Tract Infections in the Emergency Department
    Megan Lim, PharmD; Lindsay Petty, MD; Nicholas Dillman, PharmD; Pamela Walker, PharmD; Jerod Nagel, PharmD, BCPS
    Management and Outcomes of Children with Extended-Spectrum Cephalosporin-Resistant Urinary Tract Infections (ESC-R UTIs)
    Marie Wang, MD, MPH; Tara Greenhow, MD; Vivian Lee, MD; Jimmy Beck, MD; Michael Bendel-Stenzel, MD; Nicole Hames, MD; Corrie McDaniel, DO; Erin King, MD; Whitney Sherry, MD; Deepika Parmar, MD; Sara Patrizi, DO; Nivedita Srinivas, MD; Alan Schroeder, MD
    Determining the Management of Children with Acute UTI/Pyelonephritis Who Do Not Fit Current Management Recommendations.
    Barry Scanlan, MB BAO BCh MCRI; Laila Ibrahim, MBBChBAO; Sandy Hopper, MBBS; Sarah McNab, PhD; Franz Babl, MD; Andrew Davidson, MBBS FRANZCA GradDipEd MD; Penelope Bryant, PhD
    Heterogeneity of Recent Phase 3 cUTI Clinical Trials with New Antibiotics
    Almasa Bass, PharmD; Roger Echols, MD, FIDSA; Simon Portsmouth, MD; Ann Howell, MS, PharmD
    Initial Clinical Response of Children with Extended-Spectrum Cephalosporin-Resistant Urinary Tract Infections (ESC-R UTI’s) Started on Discordant Antibiotics
    Marie Wang, MD, MPH; Vivian Lee, MD; Tara Greenhow, MD; Jimmy Beck, MD; Michael Bendel-Stenzel, MD; Nicole Hames, MD; Corrie McDaniel, DO; Erin King, MD; Whitney Sherry, MD; Deepika Parmar, MD; Sara Patrizi, DO; Nivedita Srinivas, MD; Alan Schroeder, MD
    Are Providers Shifting from NTF to Fosfomycin for Inpatient UTI? Big Data Reveals Small Shifts.
    Kalpana Gupta, MD, MPH; Matthew B. Goetz, MD; Makoto Jones, MD, MS; Judith M. Strymish, MD
  • fosfonitroidsapdf.pdf (570.6 kB)
  • Oral Fosfomycin Use for Urinary Tract Infections and its Clinical Impact on Hospital Stay
    Christina Mai, MD; Henry Donaghy, MD; Thien-Ly Doan, PharmD
    A real world perspective on treatment of CRE UTIs with oral agents
    Ahmed Babiker, MBBS; Lloyd Clarke, B Sc (Hons); Ryan K. Shields, PharmD
  • IDweek Doxy vs fosfo 09.26.pdf (130.2 kB)
  • De-implementation strategy to Reduce the Inappropriate use of urinary and intravenous CATheters: the RICAT-study
    Bart J. Laan, MD; Ingrid J. B. Spijkerman, MD, PhD; Mieke H. Godfried, MD, PhD; Berend C. Pasmooij, BSc; Marjon J. Borgert, PhD; Jolanda M. Maaskant, PhD; Brent C. Opmeer, PhD; Margreet C. Vos, MD, PhD; Suzanne E. Geerlings, MD, PhD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.